论文部分内容阅读
中国已成为世界原料药的主要生产基地之一,维生素类的VC、VE、VB1、VB2、VB6,青霉素及6-APA,7-ACA,对羟基苯甘氨酸、左旋氧氟沙星、德塞美松,可的松等激素药,解热镇痛类药阿斯匹林、扑热息痛,布洛芬及巯甲丙脯酸等已在国内具有相当生产规模,其产量也居世界前三位之列。本文介绍了近年国内重点发展的医药中间体品种,及其技术开发与进展情况。
China has become one of the major production bases for the world’s raw material medicines, vitamins VC, VE, VB1, VB2, VB6, penicillin and 6-APA, 7-ACA, p-Hydroxyphenylglycine, Levofloxacin, Desaimer Pine, cortisone and other hormone drugs, antipyretic and analgesic drugs such as aspirin, paracetamol, ibuprofen and captopril have been produced in China with considerable production scale, and their output ranks among the top three in the world. . This article describes the pharmaceutical intermediates that have been developed in China in recent years, and their technological development and progress.